Dana Udall, PhD: Leading with Intention: Authenticity, Culture, and Clinical Leadership in the Health Tech Era

Psychologist-turned-operator Dana Udall (CCO, Nourish) joins Oxeon’s Dr. Reena Pande to demystify how clinician leaders scale distributed care, align clinical quality with business outcomes, and bring an intentional, ACT-informed leadership style to cross-functional teams. She urges clinicians to help inform and govern the next wave of AI-enabled care delivery.

Key Topics & Takeaways

From practice to platform: A packed waiting room revealed the limits of 1:1 care and pushed Dana toward scalable, data-driven models (Ginger/Headspace → Included Health → Nourish).


Intentional > “pure authentic”: Drawing on Acceptance & Commitment Therapy (ACT), Dana favors intentional responses over impulsive “authenticity,” fostering relationships while advancing goals.


Operating at scale in distributed telehealth:


Design intentional touchpoints from recruiting to QA.

Build data infrastructure to see quality and act early.

Treat culture (leader vulnerability, whole-self norms) as a competitive moat.


Break clinical silos with the “first-team” mindset: Clinical execs must speak Product, Commercial, Finance and be healthcare executives who happen to be clinicians.


Personal story, public leadership: In sharing her eating-disorder recovery, Dana aimed to reduce shame and inform her work at the mental–physical health intersection (e.g., food relationship + metabolic goals).


Career navigation for clinician leaders:

“Always take the call.” Have many conversations with companies, founders, VCs.

Evaluate mission integrity, leadership chemistry, true clinical quality, traction/runway, and your stage/risk tolerance.


The future of AI in care delivery: Beyond scribes, AI will influence treatment decisions. Clinicians, ethicists, and legal partners must co-design guardrails to keep patient safety central.